HIGHLIGHTS
SUMMARY
Of three data tables: demographic information "demo" table, drug information "drug" table, and adverse events information "reac" table, which included 758,542 patients, 4,076,538 cases, and 1,247,830 cases, respectively. This study investigated the signals of SREs, factors affecting the occurrence of SREs, and the time to onset of SREs in patients taking orally administered AEDs using the JADER database. Because the pharmacovigilance database is based on reports of drug-induced adverse events and the population of patients taking AEDs is unknown, it is not possible to calculate the incidence of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.